Novimmune S.A., Basel office

https://www.novimmune.com

Novimmune, a Swiss biotech company focused on the discovery and development of antibody-based drugs, announced today the opening of its branch office in Basel. The Novimmune premises at Dufourstrasse 11 will host the clinical development team and other functions to progress Novimmune’s lead compound Emapalumab towards filing for a marketing authorisation and its subsequent commercial launch in the US and Europe. *

	Start	2017-03-27 established
	Industry	clinical research
	Industry 2	emapalumab (NI-0501)

	Region	Basel BS
	Country	Switzerland
	Street	11 Dufourstr.
	City	4010 Basel BS
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Novimmune S.A.. (3/27/17). "Press Release: Novimmune Opens a Branch Office in Basel". Geneva & Basel.

		Record changed: 2023-07-10

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Novimmune S.A., Basel office

[1] Novimmune S.A.. (3/27/17). "Press Release: Novimmune Opens a Branch Office in Basel". Geneva & Basel....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]